

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive T cell selection (GO:0043368) | 8.87300334 |
| 2 | negative regulation of thymocyte apoptotic process (GO:0070244) | 8.82593734 |
| 3 | NIK/NF-kappaB signaling (GO:0038061) | 8.34200333 |
| 4 | negative T cell selection (GO:0043383) | 8.23929707 |
| 5 | regulation of gamma-delta T cell differentiation (GO:0045586) | 7.92688680 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.79602289 |
| 7 | activated T cell proliferation (GO:0050798) | 7.45048427 |
| 8 | regulation of protein polyubiquitination (GO:1902914) | 7.39867378 |
| 9 | T cell selection (GO:0045058) | 7.38011145 |
| 10 | regulation of gamma-delta T cell activation (GO:0046643) | 7.32132766 |
| 11 | regulation of necroptotic process (GO:0060544) | 6.97662389 |
| 12 | interferon-gamma production (GO:0032609) | 6.95853124 |
| 13 | necroptotic process (GO:0070266) | 6.76970833 |
| 14 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 6.76043743 |
| 15 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 6.43667374 |
| 16 | negative regulation of T-helper cell differentiation (GO:0045623) | 6.43667374 |
| 17 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.29260461 |
| 18 | alpha-beta T cell differentiation (GO:0046632) | 6.12299299 |
| 19 | T cell receptor signaling pathway (GO:0050852) | 6.11244828 |
| 20 | regulation of regulatory T cell differentiation (GO:0045589) | 6.10994747 |
| 21 | regulation of T-helper 1 cell differentiation (GO:0045625) | 6.01526071 |
| 22 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 5.85444583 |
| 23 | regulation of RIG-I signaling pathway (GO:0039535) | 5.76352563 |
| 24 | alpha-beta T cell activation (GO:0046631) | 5.75697162 |
| 25 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 5.67940297 |
| 26 | negative thymic T cell selection (GO:0045060) | 5.67275345 |
| 27 | T cell differentiation (GO:0030217) | 5.59065301 |
| 28 | negative regulation of necroptotic process (GO:0060546) | 5.44624997 |
| 29 | regulation of thymocyte apoptotic process (GO:0070243) | 5.44088564 |
| 30 | programmed necrotic cell death (GO:0097300) | 5.37863830 |
| 31 | positive thymic T cell selection (GO:0045059) | 5.32691857 |
| 32 | regulation of female gonad development (GO:2000194) | 5.28274947 |
| 33 | negative regulation of cell killing (GO:0031342) | 5.22525536 |
| 34 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.22525536 |
| 35 | necrotic cell death (GO:0070265) | 5.22114641 |
| 36 | antigen receptor-mediated signaling pathway (GO:0050851) | 5.11745464 |
| 37 | somatic cell DNA recombination (GO:0016444) | 5.09193938 |
| 38 | somatic diversification of immune receptors via germline recombination within a single locus (GO:000 | 5.09193938 |
| 39 | negative regulation of T cell apoptotic process (GO:0070233) | 4.97704302 |
| 40 | positive regulation of interleukin-2 production (GO:0032743) | 4.96090401 |
| 41 | lymphocyte costimulation (GO:0031294) | 4.91561551 |
| 42 | thymic T cell selection (GO:0045061) | 4.91453174 |
| 43 | T cell costimulation (GO:0031295) | 4.88593993 |
| 44 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 4.87259823 |
| 45 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 4.81570748 |
| 46 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.78307513 |
| 47 | Peyers patch development (GO:0048541) | 4.78171886 |
| 48 | mucosal-associated lymphoid tissue development (GO:0048537) | 4.78171886 |
| 49 | mast cell activation (GO:0045576) | 4.73976943 |
| 50 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 4.68155918 |
| 51 | mature B cell differentiation involved in immune response (GO:0002313) | 4.65669903 |
| 52 | somatic diversification of immune receptors (GO:0002200) | 4.64755544 |
| 53 | positive regulation of T cell cytokine production (GO:0002726) | 4.62594939 |
| 54 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.60812729 |
| 55 | modulation by virus of host process (GO:0019054) | 4.59086024 |
| 56 | regulation of T-helper 2 cell differentiation (GO:0045628) | 4.55062060 |
| 57 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.53773445 |
| 58 | positive regulation of calcium-mediated signaling (GO:0050850) | 4.49537934 |
| 59 | regulation of necrotic cell death (GO:0010939) | 4.41414050 |
| 60 | T cell differentiation in thymus (GO:0033077) | 4.33848655 |
| 61 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 4.33751980 |
| 62 | negative regulation of necrotic cell death (GO:0060547) | 4.32053563 |
| 63 | protein localization to Golgi apparatus (GO:0034067) | 4.25954715 |
| 64 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 4.24188876 |
| 65 | mature B cell differentiation (GO:0002335) | 4.13933131 |
| 66 | T-helper cell differentiation (GO:0042093) | 4.10252157 |
| 67 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 4.10252157 |
| 68 | response to interleukin-15 (GO:0070672) | 4.08602773 |
| 69 | T cell activation (GO:0042110) | 4.07878495 |
| 70 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.06767059 |
| 71 | T cell homeostasis (GO:0043029) | 4.04767195 |
| 72 | regulation of T cell tolerance induction (GO:0002664) | 4.02227645 |
| 73 | genitalia morphogenesis (GO:0035112) | 3.97601614 |
| 74 | leukocyte aggregation (GO:0070486) | 3.96124280 |
| 75 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.94553292 |
| 76 | lymphocyte differentiation (GO:0030098) | 3.91824190 |
| 77 | cellular response to interleukin-15 (GO:0071350) | 3.91161512 |
| 78 | regulation of memory T cell differentiation (GO:0043380) | 3.84452979 |
| 79 | regulation of interleukin-2 production (GO:0032663) | 3.81813024 |
| 80 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.80783349 |
| 81 | regulation of interleukin-13 production (GO:0032656) | 3.80463774 |
| 82 | modulation by symbiont of host cellular process (GO:0044068) | 3.77946193 |
| 83 | T cell lineage commitment (GO:0002360) | 3.76928168 |
| 84 | mast cell activation involved in immune response (GO:0002279) | 3.75606920 |
| 85 | mast cell degranulation (GO:0043303) | 3.75606920 |
| 86 | regulation of glycogen (starch) synthase activity (GO:2000465) | 3.72308199 |
| 87 | positive regulation of interleukin-4 production (GO:0032753) | 3.68527928 |
| 88 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.60513868 |
| 89 | T cell differentiation involved in immune response (GO:0002292) | 3.60513868 |
| 90 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.60513868 |
| 91 | B cell receptor signaling pathway (GO:0050853) | 3.60088413 |
| 92 | positive regulation of isotype switching (GO:0045830) | 3.59324321 |
| 93 | lymph node development (GO:0048535) | 3.58801095 |
| 94 | purine deoxyribonucleotide metabolic process (GO:0009151) | 3.56142351 |
| 95 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 3.53444846 |
| 96 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.51411015 |
| 97 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.51411015 |
| 98 | negative regulation of type 2 immune response (GO:0002829) | 3.47391230 |
| 99 | T cell mediated immunity (GO:0002456) | 3.46480893 |
| 100 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.44641172 |
| 101 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.43910655 |
| 102 | generation of neurons (GO:0048699) | 3.43456243 |
| 103 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.42181148 |
| 104 | regulation of defense response to virus by virus (GO:0050690) | 3.42158505 |
| 105 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.41524869 |
| 106 | lymphocyte homeostasis (GO:0002260) | 3.41352703 |
| 107 | B cell proliferation (GO:0042100) | 3.40462778 |
| 108 | positive regulation of granulocyte differentiation (GO:0030854) | 3.40441547 |
| 109 | protein targeting to peroxisome (GO:0006625) | 3.36815869 |
| 110 | establishment of protein localization to peroxisome (GO:0072663) | 3.36815869 |
| 111 | protein localization to peroxisome (GO:0072662) | 3.36815869 |
| 112 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.35950155 |
| 113 | regulation of T cell cytokine production (GO:0002724) | 3.35693503 |
| 114 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.35057701 |
| 115 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.35057701 |
| 116 | regulation of T-helper 1 type immune response (GO:0002825) | 3.34987204 |
| 117 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.33979913 |
| 118 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.33979913 |
| 119 | regulation of chronic inflammatory response (GO:0002676) | 3.33311826 |
| 120 | tolerance induction (GO:0002507) | 3.33046160 |
| 121 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.30931480 |
| 122 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.28148323 |
| 123 | mitochondrial fission (GO:0000266) | 3.27819558 |
| 124 | regulation of T cell differentiation (GO:0045580) | 3.27120999 |
| 125 | regulation of interleukin-4 production (GO:0032673) | 3.24319353 |
| 126 | negative regulation by host of viral transcription (GO:0043922) | 3.22542157 |
| 127 | regulation of T cell apoptotic process (GO:0070232) | 3.21431797 |
| 128 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.20364573 |
| 129 | T cell proliferation (GO:0042098) | 3.18734633 |
| 130 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.17529909 |
| 131 | regulation of B cell differentiation (GO:0045577) | 3.17181404 |
| 132 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.15391206 |
| 133 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.14262660 |
| 134 | positive regulation of T cell differentiation (GO:0045582) | 3.12744270 |
| 135 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.12494932 |
| 136 | peroxisomal transport (GO:0043574) | 3.12407679 |
| 137 | negative regulation of interleukin-17 production (GO:0032700) | 3.12125847 |
| 138 | purine nucleotide salvage (GO:0032261) | 3.09544035 |
| 139 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.06590091 |
| 140 | lymphocyte activation (GO:0046649) | 3.06589351 |
| 141 | neutrophil activation involved in immune response (GO:0002283) | 3.05332212 |
| 142 | regulation of interleukin-17 production (GO:0032660) | 3.04760606 |
| 143 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.04631676 |
| 144 | negative regulation of interleukin-10 production (GO:0032693) | 3.04459903 |
| 145 | positive regulation of T cell activation (GO:0050870) | 3.04372398 |
| 146 | regulation of calcium-mediated signaling (GO:0050848) | 3.02836112 |
| 147 | lymphocyte proliferation (GO:0046651) | 3.02689304 |
| 148 | sphingomyelin metabolic process (GO:0006684) | 3.00051737 |
| 149 | regulation of granulocyte differentiation (GO:0030852) | 2.99268046 |
| 150 | positive regulation of tolerance induction (GO:0002645) | 2.98998778 |
| 151 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.98821646 |
| 152 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.98258598 |
| 153 | regulation of isotype switching (GO:0045191) | 2.98171000 |
| 154 | T cell migration (GO:0072678) | 2.97684453 |
| 155 | positive regulation of cell killing (GO:0031343) | 2.96912549 |
| 156 | leukocyte homeostasis (GO:0001776) | 2.96804541 |
| 157 | regulation of cellular extravasation (GO:0002691) | 2.96010069 |
| 158 | peroxisome fission (GO:0016559) | 2.95855431 |
| 159 | positive regulation of DNA recombination (GO:0045911) | 2.95602166 |
| 160 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.95233707 |
| 161 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.92652312 |
| 162 | regulation of T-helper cell differentiation (GO:0045622) | 2.90165724 |
| 163 | cellular response to prostaglandin stimulus (GO:0071379) | 2.89212349 |
| 164 | regulation of alpha-beta T cell activation (GO:0046634) | 2.89204313 |
| 165 | regulation of type 2 immune response (GO:0002828) | 2.88630206 |
| 166 | I-kappaB phosphorylation (GO:0007252) | 2.88140926 |
| 167 | regulation of interleukin-10 production (GO:0032653) | 2.87834687 |
| 168 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.87660503 |
| 169 | positive regulation of alpha-beta T cell differentiation (GO:0046638) | 2.87097317 |
| 170 | positive regulation of alpha-beta T cell activation (GO:0046635) | 2.86123462 |
| 171 | positive regulation of type 2 immune response (GO:0002830) | 2.83750051 |
| 172 | V(D)J recombination (GO:0033151) | 10.6037495 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 9.71179786 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.22581954 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.50365653 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.41279685 |
| 5 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 4.10377338 |
| 6 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.85926862 |
| 7 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.76398733 |
| 8 | MYB_26560356_Chip-Seq_TH2_Human | 3.67682390 |
| 9 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 3.33548487 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.20556228 |
| 11 | MYC_22102868_ChIP-Seq_BL_Human | 3.13977708 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.98883348 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.88343288 |
| 14 | UTX_26944678_Chip-Seq_JUKART_Human | 2.70765251 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.66347602 |
| 16 | MAF_26560356_Chip-Seq_TH1_Human | 2.61436037 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.61333527 |
| 18 | MYB_26560356_Chip-Seq_TH1_Human | 2.53988776 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.53776513 |
| 20 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 2.53622591 |
| 21 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.49893084 |
| 22 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.29154705 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.21302455 |
| 24 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.12104004 |
| 25 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.06576322 |
| 26 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.05712936 |
| 27 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.01117701 |
| 28 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.95106883 |
| 29 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88600685 |
| 30 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.84025978 |
| 31 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.81223028 |
| 32 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.79868865 |
| 33 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.79271863 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.75505473 |
| 35 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.72064868 |
| 36 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.71102328 |
| 37 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.66789540 |
| 38 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.66565362 |
| 39 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.66132610 |
| 40 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.64182460 |
| 41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.62529426 |
| 42 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.60659741 |
| 43 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.60473180 |
| 44 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.55241607 |
| 45 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.53040786 |
| 46 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49893912 |
| 47 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.47435906 |
| 48 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.46832640 |
| 49 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.46093211 |
| 50 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.43509206 |
| 51 | MAF_26560356_Chip-Seq_TH2_Human | 1.40458337 |
| 52 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.35922880 |
| 53 | GATA3_26560356_Chip-Seq_TH2_Human | 1.35742942 |
| 54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.29957272 |
| 55 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.29685298 |
| 56 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.25928979 |
| 57 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.25385205 |
| 58 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21371309 |
| 59 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21169060 |
| 60 | SPI1_23127762_ChIP-Seq_K562_Human | 1.19759259 |
| 61 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.18023595 |
| 62 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.16415205 |
| 63 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14275836 |
| 64 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12163248 |
| 65 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.11573280 |
| 66 | GATA1_19941826_ChIP-Seq_K562_Human | 1.09019226 |
| 67 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06379961 |
| 68 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04419155 |
| 69 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.03318027 |
| 70 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02863786 |
| 71 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.02036575 |
| 72 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.01328678 |
| 73 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.00381863 |
| 74 | * TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00169996 |
| 75 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.97972852 |
| 76 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.97782129 |
| 77 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96662327 |
| 78 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96126278 |
| 79 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.93205385 |
| 80 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.93083915 |
| 81 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.91885503 |
| 82 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.90862627 |
| 83 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.90579865 |
| 84 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90259478 |
| 85 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89765965 |
| 86 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.88415334 |
| 87 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88158391 |
| 88 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87832063 |
| 89 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87175692 |
| 90 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.86986029 |
| 91 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.86555020 |
| 92 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.85817611 |
| 93 | * TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.84623875 |
| 94 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.84218323 |
| 95 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.84129081 |
| 96 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.84065288 |
| 97 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.83732080 |
| 98 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.83293441 |
| 99 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.81893512 |
| 100 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.79360504 |
| 101 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.78988829 |
| 102 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.78708849 |
| 103 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.77828657 |
| 104 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.77585974 |
| 105 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.75877525 |
| 106 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.75598137 |
| 107 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74913905 |
| 108 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.74795022 |
| 109 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.74461237 |
| 110 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.73860967 |
| 111 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.72865193 |
| 112 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.70567869 |
| 113 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.68039487 |
| 114 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.67916035 |
| 115 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.66202959 |
| 116 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.64057983 |
| 117 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.63991546 |
| 118 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.63819856 |
| 119 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.63095114 |
| 120 | * RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.63025208 |
| 121 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.62100349 |
| 122 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.61983276 |
| 123 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.61830626 |
| 124 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.59048570 |
| 125 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.58167497 |
| 126 | GATA3_26560356_Chip-Seq_TH1_Human | 0.56921117 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 5.46553687 |
| 2 | MP0005671_abnormal_response_to | 4.62747033 |
| 3 | MP0002166_altered_tumor_susceptibility | 4.04380092 |
| 4 | MP0005409_darkened_coat_color | 3.98095344 |
| 5 | * MP0000703_abnormal_thymus_morphology | 3.45897386 |
| 6 | MP0002132_abnormal_respiratory_system | 3.39908235 |
| 7 | MP0002006_tumorigenesis | 3.27556437 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.22347686 |
| 9 | MP0001835_abnormal_antigen_presentation | 3.15882335 |
| 10 | MP0009785_altered_susceptibility_to | 2.84180474 |
| 11 | MP0000685_abnormal_immune_system | 2.82497771 |
| 12 | MP0005387_immune_system_phenotype | 2.65730315 |
| 13 | MP0001790_abnormal_immune_system | 2.65730315 |
| 14 | MP0004947_skin_inflammation | 2.63728920 |
| 15 | * MP0002398_abnormal_bone_marrow | 2.59899675 |
| 16 | MP0001800_abnormal_humoral_immune | 2.56203192 |
| 17 | MP0002933_joint_inflammation | 2.32694961 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.30261549 |
| 19 | MP0006082_CNS_inflammation | 2.29844657 |
| 20 | MP0001819_abnormal_immune_cell | 2.28528275 |
| 21 | MP0005000_abnormal_immune_tolerance | 2.27246878 |
| 22 | MP0000015_abnormal_ear_pigmentation | 2.26797594 |
| 23 | MP0002723_abnormal_immune_serum | 2.23353276 |
| 24 | MP0003300_gastrointestinal_ulcer | 2.21703823 |
| 25 | * MP0000716_abnormal_immune_system | 2.19855822 |
| 26 | * MP0002722_abnormal_immune_system | 2.18764996 |
| 27 | MP0001873_stomach_inflammation | 2.18700650 |
| 28 | MP0005174_abnormal_tail_pigmentation | 2.15328498 |
| 29 | MP0002405_respiratory_system_inflammati | 2.14660090 |
| 30 | * MP0010155_abnormal_intestine_physiology | 2.13345421 |
| 31 | MP0009333_abnormal_splenocyte_physiolog | 2.05871162 |
| 32 | MP0000689_abnormal_spleen_morphology | 1.98040582 |
| 33 | MP0002452_abnormal_antigen_presenting | 1.97492564 |
| 34 | MP0008877_abnormal_DNA_methylation | 1.97056311 |
| 35 | MP0005025_abnormal_response_to | 1.95816079 |
| 36 | MP0009278_abnormal_bone_marrow | 1.93074602 |
| 37 | MP0010094_abnormal_chromosome_stability | 1.92716518 |
| 38 | MP0002095_abnormal_skin_pigmentation | 1.91223479 |
| 39 | MP0004808_abnormal_hematopoietic_stem | 1.88769794 |
| 40 | MP0001853_heart_inflammation | 1.88594385 |
| 41 | MP0002148_abnormal_hypersensitivity_rea | 1.87040239 |
| 42 | MP0003303_peritoneal_inflammation | 1.75756711 |
| 43 | * MP0002429_abnormal_blood_cell | 1.70937744 |
| 44 | MP0005310_abnormal_salivary_gland | 1.68490349 |
| 45 | MP0003724_increased_susceptibility_to | 1.67924043 |
| 46 | MP0001188_hyperpigmentation | 1.59311582 |
| 47 | MP0005397_hematopoietic_system_phenotyp | 1.57146975 |
| 48 | MP0001545_abnormal_hematopoietic_system | 1.57146975 |
| 49 | MP0002009_preneoplasia | 1.57020191 |
| 50 | MP0001849_ear_inflammation | 1.55227018 |
| 51 | MP0002127_abnormal_cardiovascular_syste | 1.50772388 |
| 52 | MP0001764_abnormal_homeostasis | 1.44607281 |
| 53 | MP0002138_abnormal_hepatobiliary_system | 1.43562920 |
| 54 | MP0003453_abnormal_keratinocyte_physiol | 1.42896729 |
| 55 | MP0001177_atelectasis | 1.42850803 |
| 56 | MP0002396_abnormal_hematopoietic_system | 1.42215391 |
| 57 | MP0002419_abnormal_innate_immunity | 1.36994144 |
| 58 | MP0000490_abnormal_crypts_of | 1.36582294 |
| 59 | MP0003183_abnormal_peptide_metabolism | 1.34872284 |
| 60 | * MP0001845_abnormal_inflammatory_respons | 1.32080292 |
| 61 | MP0002876_abnormal_thyroid_physiology | 1.29129674 |
| 62 | MP0000681_abnormal_thyroid_gland | 1.26712663 |
| 63 | MP0004381_abnormal_hair_follicle | 1.23028029 |
| 64 | MP0003866_abnormal_defecation | 1.21903296 |
| 65 | MP0000678_abnormal_parathyroid_gland | 1.21690797 |
| 66 | MP0001879_abnormal_lymphatic_vessel | 1.18735892 |
| 67 | MP0009697_abnormal_copulation | 1.15093489 |
| 68 | MP0003787_abnormal_imprinting | 1.13958843 |
| 69 | MP0003868_abnormal_feces_composition | 1.10179172 |
| 70 | MP0005464_abnormal_platelet_physiology | 1.09076865 |
| 71 | MP0003436_decreased_susceptibility_to | 1.05578116 |
| 72 | MP0002998_abnormal_bone_remodeling | 1.01223037 |
| 73 | MP0004510_myositis | 1.00199118 |
| 74 | MP0002075_abnormal_coat/hair_pigmentati | 0.99700607 |
| 75 | MP0008007_abnormal_cellular_replicative | 0.99131860 |
| 76 | MP0005266_abnormal_metabolism | 0.98739180 |
| 77 | MP0002089_abnormal_postnatal_growth/wei | 0.98370531 |
| 78 | MP0000858_altered_metastatic_potential | 0.92703210 |
| 79 | MP0008057_abnormal_DNA_replication | 0.92672566 |
| 80 | MP0004883_abnormal_blood_vessel | 0.92358341 |
| 81 | MP0003252_abnormal_bile_duct | 0.90012638 |
| 82 | MP0000383_abnormal_hair_follicle | 0.89205812 |
| 83 | MP0005376_homeostasis/metabolism_phenot | 0.88978828 |
| 84 | MP0002019_abnormal_tumor_incidence | 0.85942865 |
| 85 | MP0001348_abnormal_lacrimal_gland | 0.83429571 |
| 86 | MP0003123_paternal_imprinting | 0.82191275 |
| 87 | MP0001243_abnormal_dermal_layer | 0.80441991 |
| 88 | MP0001663_abnormal_digestive_system | 0.79999853 |
| 89 | MP0005535_abnormal_body_temperature | 0.77950738 |
| 90 | MP0002837_dystrophic_cardiac_calcinosis | 0.77412480 |
| 91 | MP0001186_pigmentation_phenotype | 0.76747883 |
| 92 | MP0003646_muscle_fatigue | 0.76370530 |
| 93 | MP0001666_abnormal_nutrient_absorption | 0.74924738 |
| 94 | MP0000372_irregular_coat_pigmentation | 0.74168608 |
| 95 | MP0009115_abnormal_fat_cell | 0.73890111 |
| 96 | MP0005075_abnormal_melanosome_morpholog | 0.73773632 |
| 97 | MP0001919_abnormal_reproductive_system | 0.73298783 |
| 98 | MP0000465_gastrointestinal_hemorrhage | 0.72437452 |
| 99 | MP0003045_fibrosis | 0.72167843 |
| 100 | MP0008058_abnormal_DNA_repair | 0.68705293 |
| 101 | MP0005076_abnormal_cell_differentiation | 0.68670803 |
| 102 | MP0008569_lethality_at_weaning | 0.68039898 |
| 103 | MP0001216_abnormal_epidermal_layer | 0.67479226 |
| 104 | MP0005410_abnormal_fertilization | 0.67188865 |
| 105 | MP0008961_abnormal_basal_metabolism | 0.67079390 |
| 106 | MP0001851_eye_inflammation | 0.65816556 |
| 107 | MP0005388_respiratory_system_phenotype | 0.65340271 |
| 108 | MP0002133_abnormal_respiratory_system | 0.65340271 |
| 109 | MP0001191_abnormal_skin_condition | 0.65330253 |
| 110 | MP0005451_abnormal_body_composition | 0.64828934 |
| 111 | MP0003448_altered_tumor_morphology | 0.64814047 |
| 112 | MP0008469_abnormal_protein_level | 0.63916985 |
| 113 | MP0000920_abnormal_myelination | 0.62642271 |
| 114 | MP0009672_abnormal_birth_weight | 0.62493608 |
| 115 | MP0004036_abnormal_muscle_relaxation | 0.61096714 |
| 116 | MP0002971_abnormal_brown_adipose | 0.59982597 |
| 117 | MP0008873_increased_physiological_sensi | 0.59366216 |
| 118 | MP0000313_abnormal_cell_death | 0.58909044 |
| 119 | MP0003959_abnormal_lean_body | 0.57334736 |
| 120 | MP0002163_abnormal_gland_morphology | 0.57111424 |
| 121 | MP0001664_abnormal_digestion | 0.56982530 |
| 122 | MP0003795_abnormal_bone_structure | 0.56763475 |
| 123 | MP0000750_abnormal_muscle_regeneration | 0.53570540 |
| 124 | MP0000249_abnormal_blood_vessel | 0.51701030 |
| 125 | MP0001533_abnormal_skeleton_physiology | 0.51469129 |
| 126 | MP0000477_abnormal_intestine_morphology | 0.50993045 |
| 127 | MP0003693_abnormal_embryo_hatching | 0.50872465 |
| 128 | MP0003077_abnormal_cell_cycle | 0.49500638 |
| 129 | MP0003943_abnormal_hepatobiliary_system | 0.48521460 |
| 130 | MP0000367_abnormal_coat/_hair | 0.48156537 |
| 131 | MP0009765_abnormal_xenobiotic_induced | 0.46925319 |
| 132 | MP0010352_gastrointestinal_tract_polyps | 0.46237758 |
| 133 | MP0002083_premature_death | 0.46006944 |
| 134 | MP0000627_abnormal_mammary_gland | 0.45720915 |
| 135 | MP0006035_abnormal_mitochondrial_morpho | 0.43467063 |
| 136 | MP0004130_abnormal_muscle_cell | 0.43375287 |
| 137 | MP0003828_pulmonary_edema | 0.42917019 |
| 138 | MP0005389_reproductive_system_phenotype | 0.41234634 |
| 139 | MP0008770_decreased_survivor_rate | 0.40547473 |
| 140 | MP0005381_digestive/alimentary_phenotyp | 0.39665974 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B lymphocytopenia (HP:0010976) | 9.84928002 |
| 2 | Abnormality of B cell number (HP:0010975) | 9.84928002 |
| 3 | Abnormality of T cell number (HP:0011839) | 9.77209474 |
| 4 | Severe combined immunodeficiency (HP:0004430) | 8.99794815 |
| 5 | Hypoplasia of the thymus (HP:0000778) | 8.51801417 |
| 6 | Thyroiditis (HP:0100646) | 8.47054028 |
| 7 | Panhypogammaglobulinemia (HP:0003139) | 8.12685988 |
| 8 | Combined immunodeficiency (HP:0005387) | 7.78630595 |
| 9 | Eosinophilia (HP:0001880) | 7.19591397 |
| 10 | Recurrent viral infections (HP:0004429) | 6.24030569 |
| 11 | Hypoproteinemia (HP:0003075) | 6.17003687 |
| 12 | Granulocytopenia (HP:0001913) | 5.87260457 |
| 13 | Abnormality of eosinophils (HP:0001879) | 5.78041801 |
| 14 | Abnormality of T cells (HP:0002843) | 5.30051316 |
| 15 | Thin bony cortex (HP:0002753) | 5.12868339 |
| 16 | Abnormality of the costochondral junction (HP:0000919) | 4.96191000 |
| 17 | Enlarged epiphyses (HP:0010580) | 4.76760468 |
| 18 | Neonatal respiratory distress (HP:0002643) | 4.70344072 |
| 19 | IgG deficiency (HP:0004315) | 4.69819231 |
| 20 | Recurrent fungal infections (HP:0002841) | 4.68690586 |
| 21 | Metaphyseal dysplasia (HP:0100255) | 4.64127311 |
| 22 | Ankyloglossia (HP:0010296) | 4.40035895 |
| 23 | Leukocytosis (HP:0001974) | 4.30691451 |
| 24 | Erythroderma (HP:0001019) | 3.99572739 |
| 25 | Retrobulbar optic neuritis (HP:0100654) | 3.98931463 |
| 26 | Optic neuritis (HP:0100653) | 3.98931463 |
| 27 | Brushfield spots (HP:0001088) | 3.97171615 |
| 28 | Myositis (HP:0100614) | 3.85702194 |
| 29 | Delayed epiphyseal ossification (HP:0002663) | 3.74235875 |
| 30 | Limb hypertonia (HP:0002509) | 3.72408819 |
| 31 | Submucous cleft hard palate (HP:0000176) | 3.61038988 |
| 32 | Meningitis (HP:0001287) | 3.58265146 |
| 33 | Orchitis (HP:0100796) | 3.42874053 |
| 34 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 3.41259705 |
| 35 | Papilledema (HP:0001085) | 3.39164569 |
| 36 | Thickened helices (HP:0000391) | 3.26775556 |
| 37 | Widely patent fontanelles and sutures (HP:0004492) | 3.22391595 |
| 38 | Abnormality of oral frenula (HP:0000190) | 3.21517832 |
| 39 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.09386009 |
| 40 | Abnormality of the fingertips (HP:0001211) | 3.08516206 |
| 41 | Colitis (HP:0002583) | 3.07437884 |
| 42 | Acute hepatic failure (HP:0006554) | 2.99004770 |
| 43 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.91360646 |
| 44 | Increased IgE level (HP:0003212) | 2.90704997 |
| 45 | Abnormal epiphyseal ossification (HP:0010656) | 2.90345772 |
| 46 | Gastrointestinal inflammation (HP:0004386) | 2.88802380 |
| 47 | Keratoconjunctivitis sicca (HP:0001097) | 2.82538111 |
| 48 | Alveolar cell carcinoma (HP:0006519) | 2.69363679 |
| 49 | Encephalitis (HP:0002383) | 2.66561600 |
| 50 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 2.65588006 |
| 51 | Metaphyseal irregularity (HP:0003025) | 2.62923714 |
| 52 | Abnormality of the prostate (HP:0008775) | 2.62107087 |
| 53 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.60299585 |
| 54 | Keratoconjunctivitis (HP:0001096) | 2.58570781 |
| 55 | IgA deficiency (HP:0002720) | 2.58551717 |
| 56 | Hemoptysis (HP:0002105) | 2.57476789 |
| 57 | Spinal cord lesions (HP:0100561) | 2.47706091 |
| 58 | Syringomyelia (HP:0003396) | 2.47706091 |
| 59 | Progressive microcephaly (HP:0000253) | 2.44278247 |
| 60 | Cavernous hemangioma (HP:0001048) | 2.44220412 |
| 61 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.42039128 |
| 62 | Recurrent cutaneous fungal infections (HP:0011370) | 2.42039128 |
| 63 | Flat occiput (HP:0005469) | 2.41244254 |
| 64 | Thoracic kyphosis (HP:0002942) | 2.40601037 |
| 65 | Beaking of vertebral bodies (HP:0004568) | 2.38874733 |
| 66 | Lymphoma (HP:0002665) | 2.38617256 |
| 67 | Abnormality of the thymus (HP:0000777) | 2.35990219 |
| 68 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 2.35782109 |
| 69 | Abnormality of the periventricular white matter (HP:0002518) | 2.35130330 |
| 70 | Pulmonary infiltrates (HP:0002113) | 2.34468950 |
| 71 | Hypophosphatemia (HP:0002148) | 2.31419408 |
| 72 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.31357156 |
| 73 | Short middle phalanx of the 5th finger (HP:0004220) | 2.28434378 |
| 74 | IgM deficiency (HP:0002850) | 2.28162938 |
| 75 | Volvulus (HP:0002580) | 2.27449244 |
| 76 | Gangrene (HP:0100758) | 2.27113425 |
| 77 | Autoimmune thrombocytopenia (HP:0001973) | 2.26098420 |
| 78 | Thickened calvaria (HP:0002684) | 2.25587352 |
| 79 | Thickened nuchal skin fold (HP:0000474) | 2.23712705 |
| 80 | Vasculitis (HP:0002633) | 2.21181223 |
| 81 | Spondylolisthesis (HP:0003302) | 2.19788576 |
| 82 | Short foot (HP:0001773) | 2.19664618 |
| 83 | Chronic obstructive pulmonary disease (HP:0006510) | 2.14000787 |
| 84 | Obstructive lung disease (HP:0006536) | 2.14000787 |
| 85 | Menstrual irregularities (HP:0000858) | 2.13788449 |
| 86 | Hypoglycemic seizures (HP:0002173) | 2.12314802 |
| 87 | Abnormality of the pubic bones (HP:0003172) | 2.12303654 |
| 88 | Pulmonary embolism (HP:0002204) | 2.11793758 |
| 89 | Stomatitis (HP:0010280) | 2.11267266 |
| 90 | Epiphyseal stippling (HP:0010655) | 2.10427818 |
| 91 | Thoracolumbar scoliosis (HP:0002944) | 2.06891353 |
| 92 | Abnormality of DNA repair (HP:0003254) | 2.06369947 |
| 93 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 2.05160451 |
| 94 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.04771896 |
| 95 | Cellular immunodeficiency (HP:0005374) | 2.03725510 |
| 96 | Mask-like facies (HP:0000298) | 2.02285844 |
| 97 | T lymphocytopenia (HP:0005403) | 10.2252823 |
| 98 | Autoimmune hemolytic anemia (HP:0001890) | 1.99950093 |
| 99 | Abnormality of the 2nd finger (HP:0004100) | 1.99674972 |
| 100 | Severe global developmental delay (HP:0011344) | 1.98767309 |
| 101 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.98015287 |
| 102 | Barrel-shaped chest (HP:0001552) | 1.97819781 |
| 103 | Deep palmar crease (HP:0006191) | 1.96622709 |
| 104 | Ureteral stenosis (HP:0000071) | 1.95566750 |
| 105 | Sepsis (HP:0100806) | 1.94802982 |
| 106 | Chromsome breakage (HP:0040012) | 1.94800135 |
| 107 | Eczematoid dermatitis (HP:0000976) | 1.94075778 |
| 108 | Arterial thrombosis (HP:0004420) | 1.94032593 |
| 109 | Ureteral obstruction (HP:0006000) | 1.88363768 |
| 110 | Thrombocytosis (HP:0001894) | 1.88021991 |
| 111 | Partial agenesis of the corpus callosum (HP:0001338) | 1.88017272 |
| 112 | Deep philtrum (HP:0002002) | 1.87922496 |
| 113 | Increased IgM level (HP:0003496) | 1.87789275 |
| 114 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.87110291 |
| 115 | Difficulty walking (HP:0002355) | 1.84820894 |
| 116 | Acute lymphatic leukemia (HP:0006721) | 1.84201377 |
| 117 | Congenital primary aphakia (HP:0007707) | 1.83970748 |
| 118 | Nephrogenic diabetes insipidus (HP:0009806) | 1.83647197 |
| 119 | Rickets (HP:0002748) | 1.82436564 |
| 120 | Pustule (HP:0200039) | 1.80940465 |
| 121 | Joint swelling (HP:0001386) | 1.80366206 |
| 122 | Lymphopenia (HP:0001888) | 1.78698274 |
| 123 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.75442047 |
| 124 | Glomerulopathy (HP:0100820) | 1.72717462 |
| 125 | Recurrent bronchitis (HP:0002837) | 1.69580091 |
| 126 | Chronic diarrhea (HP:0002028) | 1.65921619 |
| 127 | Spontaneous hematomas (HP:0007420) | 1.63681020 |
| 128 | Bicuspid aortic valve (HP:0001647) | 1.62639091 |
| 129 | Chest pain (HP:0100749) | 1.62310853 |
| 130 | Abnormality of the pleura (HP:0002103) | 1.62300548 |
| 131 | Chronic otitis media (HP:0000389) | 1.60435413 |
| 132 | Type 2 muscle fiber atrophy (HP:0003554) | 1.59243336 |
| 133 | Abnormal hair whorl (HP:0010721) | 1.58636997 |
| 134 | Gastrointestinal infarctions (HP:0005244) | 1.55722760 |
| 135 | Verrucae (HP:0200043) | 1.53150047 |
| 136 | Papilloma (HP:0012740) | 1.53150047 |
| 137 | Muscle fiber atrophy (HP:0100295) | 1.51523313 |
| 138 | Keratitis (HP:0000491) | 1.49851871 |
| 139 | Recurrent skin infections (HP:0001581) | 1.48169131 |
| 140 | Abnormality of T cell physiology (HP:0011840) | 1.46731044 |
| 141 | Abnormality of male internal genitalia (HP:0000022) | 1.46525343 |
| 142 | Bronchiectasis (HP:0002110) | 1.45101371 |
| 143 | Epistaxis (HP:0000421) | 1.42763136 |
| 144 | Abnormality of the pericardium (HP:0001697) | 1.41641359 |
| 145 | Acute myeloid leukemia (HP:0004808) | 1.41596303 |
| 146 | Pruritus (HP:0000989) | 1.41019819 |
| 147 | Mediastinal lymphadenopathy (HP:0100721) | 1.40453440 |
| 148 | Recurrent abscess formation (HP:0002722) | 1.38609124 |
| 149 | Agammaglobulinemia (HP:0004432) | 1.30028992 |
| 150 | Polyneuropathy (HP:0001271) | 1.29262019 |
| 151 | Aortic valve stenosis (HP:0001650) | 1.28422409 |
| 152 | Cutis marmorata (HP:0000965) | 1.26920020 |
| 153 | Thrombophlebitis (HP:0004418) | 1.26861258 |
| 154 | Recurrent bacterial skin infections (HP:0005406) | 1.24753143 |
| 155 | Recurrent sinusitis (HP:0011108) | 1.23838871 |
| 156 | Weak cry (HP:0001612) | 1.23212597 |
| 157 | Long eyelashes (HP:0000527) | 1.23049104 |
| 158 | Inflammation of the large intestine (HP:0002037) | 1.21395709 |
| 159 | Abnormality of the endocardium (HP:0004306) | 1.20889507 |
| 160 | Prostate neoplasm (HP:0100787) | 1.20245324 |
| 161 | Prolonged bleeding time (HP:0003010) | 1.17745824 |
| 162 | Anorexia (HP:0002039) | 1.16885293 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | AKT3 | 5.37110734 |
| 2 | MAP4K1 | 3.88805304 |
| 3 | YES1 | 2.91032325 |
| 4 | ZAP70 | 2.75035669 |
| 5 | ICK | 2.58101799 |
| 6 | ITK | 2.34136952 |
| 7 | PRKD3 | 2.33640786 |
| 8 | MST4 | 2.31907039 |
| 9 | BRAF | 2.28539014 |
| 10 | ERN1 | 2.24916479 |
| 11 | SYK | 2.01487162 |
| 12 | TXK | 10.9608837 |
| 13 | GRK6 | 1.94054261 |
| 14 | NLK | 1.92010922 |
| 15 | MAPK7 | 1.80172610 |
| 16 | PDGFRB | 1.62219499 |
| 17 | TNIK | 1.62206091 |
| 18 | LCK | 1.60365827 |
| 19 | JAK3 | 1.59891983 |
| 20 | STK10 | 1.59730998 |
| 21 | TEC | 1.53708887 |
| 22 | FGFR3 | 1.42593270 |
| 23 | CSK | 1.41062397 |
| 24 | TYK2 | 1.40769136 |
| 25 | HCK | 1.39368683 |
| 26 | MAP3K2 | 1.37335802 |
| 27 | FGFR4 | 1.33307412 |
| 28 | IKBKE | 1.32558689 |
| 29 | MAP3K14 | 1.29093640 |
| 30 | CLK1 | 1.25650969 |
| 31 | PASK | 1.19724335 |
| 32 | PRKCQ | 1.18111008 |
| 33 | CDK12 | 1.16004884 |
| 34 | CAMKK2 | 1.15906974 |
| 35 | IRAK4 | 1.15559539 |
| 36 | PDK2 | 1.15305599 |
| 37 | CDK3 | 1.11967616 |
| 38 | BTK | 1.11239547 |
| 39 | SMG1 | 1.10299916 |
| 40 | SGK494 | 1.07720731 |
| 41 | SGK223 | 1.07720731 |
| 42 | MAP3K7 | 1.03819066 |
| 43 | JAK1 | 0.93066097 |
| 44 | PRKD2 | 0.90765199 |
| 45 | ADRBK2 | 0.89787946 |
| 46 | SIK3 | 0.89310590 |
| 47 | FRK | 0.88640490 |
| 48 | MAPK12 | 0.88442969 |
| 49 | BRD4 | 0.87185452 |
| 50 | CSNK1A1L | 0.86082398 |
| 51 | HIPK2 | 0.85196259 |
| 52 | FLT3 | 0.84298039 |
| 53 | CDK7 | 0.80553958 |
| 54 | PIK3CG | 0.78447935 |
| 55 | PRPF4B | 0.76719878 |
| 56 | CDK6 | 0.75607686 |
| 57 | JAK2 | 0.74416183 |
| 58 | STK4 | 0.73425575 |
| 59 | MAPK4 | 0.72296637 |
| 60 | TAOK3 | 0.71189486 |
| 61 | PRKCH | 0.70287407 |
| 62 | NME2 | 0.70146592 |
| 63 | TBK1 | 0.66134533 |
| 64 | PIM1 | 0.65814006 |
| 65 | FGFR2 | 0.65602531 |
| 66 | MARK2 | 0.63994636 |
| 67 | CSNK1G3 | 0.62784040 |
| 68 | SIK2 | 0.61313455 |
| 69 | EPHA3 | 0.60631687 |
| 70 | MAP3K10 | 0.60162534 |
| 71 | LYN | 0.59404408 |
| 72 | RIPK4 | 0.57820042 |
| 73 | PDK1 | 0.57200535 |
| 74 | NUAK1 | 0.56174218 |
| 75 | KIT | 0.55978444 |
| 76 | MAP2K3 | 0.55897311 |
| 77 | CHEK1 | 0.55350736 |
| 78 | MAP3K13 | 0.54091584 |
| 79 | IKBKB | 0.52748332 |
| 80 | MAPK10 | 0.52684583 |
| 81 | MKNK2 | 0.52595102 |
| 82 | EPHB1 | 0.52576389 |
| 83 | FYN | 0.51698010 |
| 84 | MAPK13 | 0.50693725 |
| 85 | CSNK1G1 | 0.49660873 |
| 86 | MAPK11 | 0.49096885 |
| 87 | CHUK | 0.48946415 |
| 88 | EIF2AK3 | 0.48524058 |
| 89 | CDK9 | 0.48230987 |
| 90 | INSR | 0.48197635 |
| 91 | BMPR2 | 0.47367778 |
| 92 | SGK1 | 0.47242652 |
| 93 | FES | 0.46625682 |
| 94 | MAP2K2 | 0.46534652 |
| 95 | TNK2 | 0.46239920 |
| 96 | SGK3 | 0.46184001 |
| 97 | STK24 | 0.44390929 |
| 98 | TSSK6 | 0.44367666 |
| 99 | TAOK1 | 0.43826903 |
| 100 | CAMK1 | 0.42828131 |
| 101 | RPS6KA4 | 0.42752142 |
| 102 | CSNK1G2 | 0.42485791 |
| 103 | RPS6KB2 | 0.41956263 |
| 104 | TRIB3 | 0.40945697 |
| 105 | NEK2 | 0.39494583 |
| 106 | CSF1R | 0.38877290 |
| 107 | CDC42BPA | 0.38349869 |
| 108 | CAMK4 | 0.38096820 |
| 109 | CDK4 | 0.37126021 |
| 110 | MAPK3 | 0.35974173 |
| 111 | CDC7 | 0.35237745 |
| 112 | RPS6KA5 | 0.35117963 |
| 113 | PTK6 | 0.33871863 |
| 114 | PKN2 | 0.32875289 |
| 115 | MARK3 | 0.32044358 |
| 116 | LRRK2 | 0.31826537 |
| 117 | MELK | 0.30943383 |
| 118 | OBSCN | 0.30679023 |
| 119 | PRKD1 | 0.30275891 |
| 120 | CAMKK1 | 0.28439679 |
| 121 | PRKG2 | 0.27016239 |
| 122 | SGK2 | 0.26379742 |
| 123 | ATR | 0.26242560 |
| 124 | EEF2K | 0.26144095 |
| 125 | IRAK1 | 0.24979816 |
| 126 | SRPK1 | 0.24929892 |
| 127 | EIF2AK2 | 0.24744089 |
| 128 | AKT2 | 0.24575673 |
| 129 | BLK | 0.24340716 |
| 130 | ABL1 | 0.22876238 |
| 131 | ATM | 0.20621624 |
| 132 | MAPKAPK2 | 0.20443178 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 7.78790714 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 4.40221936 |
| 3 | Sulfur metabolism_Homo sapiens_hsa00920 | 4.01833764 |
| 4 | Non-homologous end-joining_Homo sapiens_hsa03450 | 3.52103370 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.87159748 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.85427393 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.81035819 |
| 8 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.68590799 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.63339156 |
| 10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.36609251 |
| 11 | * Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.36262268 |
| 12 | Measles_Homo sapiens_hsa05162 | 2.19774400 |
| 13 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.08359600 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.95549441 |
| 15 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.80859889 |
| 16 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.65743501 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.62616141 |
| 18 | Asthma_Homo sapiens_hsa05310 | 1.62117584 |
| 19 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.61250344 |
| 20 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.58445269 |
| 21 | Alcoholism_Homo sapiens_hsa05034 | 1.51909800 |
| 22 | Thyroid cancer_Homo sapiens_hsa05216 | 1.48145108 |
| 23 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.42881047 |
| 24 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.41620047 |
| 25 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.24548394 |
| 26 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.22802481 |
| 27 | Colorectal cancer_Homo sapiens_hsa05210 | 1.22794332 |
| 28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.20110457 |
| 29 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.19611152 |
| 30 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.14099537 |
| 31 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.12943617 |
| 32 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.12365698 |
| 33 | Homologous recombination_Homo sapiens_hsa03440 | 1.12144397 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.11889544 |
| 35 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.11104690 |
| 36 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.10234586 |
| 37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.07141466 |
| 38 | Hepatitis B_Homo sapiens_hsa05161 | 1.02979708 |
| 39 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.02838612 |
| 40 | Endometrial cancer_Homo sapiens_hsa05213 | 1.00268008 |
| 41 | HTLV-I infection_Homo sapiens_hsa05166 | 0.96491079 |
| 42 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.95539881 |
| 43 | * Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.94916333 |
| 44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.93185397 |
| 45 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.92994355 |
| 46 | Influenza A_Homo sapiens_hsa05164 | 0.86417695 |
| 47 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.85995227 |
| 48 | Prostate cancer_Homo sapiens_hsa05215 | 0.84389206 |
| 49 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80455244 |
| 50 | Viral myocarditis_Homo sapiens_hsa05416 | 0.80421901 |
| 51 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.77572106 |
| 52 | Circadian rhythm_Homo sapiens_hsa04710 | 0.77550897 |
| 53 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.76562636 |
| 54 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.74679985 |
| 55 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.74351627 |
| 56 | Spliceosome_Homo sapiens_hsa03040 | 0.74215735 |
| 57 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.73561899 |
| 58 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.73322676 |
| 59 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.71266210 |
| 60 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.66910178 |
| 61 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.66618207 |
| 62 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.65836136 |
| 63 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.65788103 |
| 64 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.65585546 |
| 65 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.64837148 |
| 66 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.64532365 |
| 67 | Platelet activation_Homo sapiens_hsa04611 | 0.64390912 |
| 68 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.62209793 |
| 69 | Adherens junction_Homo sapiens_hsa04520 | 0.59883246 |
| 70 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.59419455 |
| 71 | Malaria_Homo sapiens_hsa05144 | 0.59279468 |
| 72 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.57603902 |
| 73 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56334415 |
| 74 | Apoptosis_Homo sapiens_hsa04210 | 0.56244521 |
| 75 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56218990 |
| 76 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.56144636 |
| 77 | Shigellosis_Homo sapiens_hsa05131 | 0.55966567 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55726105 |
| 79 | Cell cycle_Homo sapiens_hsa04110 | 0.55198019 |
| 80 | Pertussis_Homo sapiens_hsa05133 | 0.55131615 |
| 81 | Long-term depression_Homo sapiens_hsa04730 | 0.54611529 |
| 82 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.54102803 |
| 83 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.53261110 |
| 84 | RNA degradation_Homo sapiens_hsa03018 | 0.52392601 |
| 85 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.51067239 |
| 86 | Tuberculosis_Homo sapiens_hsa05152 | 0.50591678 |
| 87 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.48609515 |
| 88 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.48025862 |
| 89 | Morphine addiction_Homo sapiens_hsa05032 | 0.47336401 |
| 90 | Insulin resistance_Homo sapiens_hsa04931 | 0.46142593 |
| 91 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.44764791 |
| 92 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.44525549 |
| 93 | DNA replication_Homo sapiens_hsa03030 | 0.44256425 |
| 94 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.44017688 |
| 95 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.42890519 |
| 96 | Glioma_Homo sapiens_hsa05214 | 0.42878148 |
| 97 | Legionellosis_Homo sapiens_hsa05134 | 0.41511978 |
| 98 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.41213880 |
| 99 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.40549685 |
| 100 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.40466267 |
| 101 | Lysine degradation_Homo sapiens_hsa00310 | 0.40046769 |
| 102 | Base excision repair_Homo sapiens_hsa03410 | 0.39804323 |
| 103 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.39177464 |
| 104 | Hepatitis C_Homo sapiens_hsa05160 | 0.38922974 |
| 105 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.38724060 |
| 106 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.38537022 |
| 107 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.37955280 |
| 108 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.37351159 |
| 109 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37134426 |
| 110 | Pathways in cancer_Homo sapiens_hsa05200 | 0.36483751 |
| 111 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.36238506 |
| 112 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.35513803 |
| 113 | Mismatch repair_Homo sapiens_hsa03430 | 0.34251317 |
| 114 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.34217251 |
| 115 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.33033756 |
| 116 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.32905764 |
| 117 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.31970727 |
| 118 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.31869486 |
| 119 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.31625025 |
| 120 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.31522206 |
| 121 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.29973293 |
| 122 | Long-term potentiation_Homo sapiens_hsa04720 | 0.29750066 |
| 123 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.27781986 |
| 124 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.26583883 |
| 125 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.26421442 |
| 126 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.26234329 |
| 127 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.24229234 |
| 128 | Salmonella infection_Homo sapiens_hsa05132 | 0.23777666 |
| 129 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.22907288 |
| 130 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.22837489 |
| 131 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.22723969 |
| 132 | Basal transcription factors_Homo sapiens_hsa03022 | 0.20348728 |
| 133 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.19157356 |
| 134 | Melanogenesis_Homo sapiens_hsa04916 | 0.17012598 |

